Cancer Clinical Investigation

Search results

• Mount Sinai Researchers Find New, Safer Treatment for Serious Side Effect of Bone Marrow Transplant

  John Levine & Aaron Etra

  14/12/22 → 16/12/22

  3 items of Media coverage

  Press/Media

• Epigenetic, Immunotherapy Combo Effective in Mantle Cell Lymphoma

  Samir Parekh & Violetta V. Leshchenko

  14/12/22

  1 item of Media coverage

  Press/Media

• Mount Sinai's Dubin Breast Cancer Center Raises $3 Million for 12th Anniversary.

  Hanna Irie

  14/12/22

  1 item of Media coverage

  Press/Media

• Mount Sinai’s Dubin Breast Cancer Center Raises $3 Million for 12th Anniversary

  Hanna Irie

  14/12/22

  57 items of Media coverage

  Press/Media

• Mount Sinai researchers find new, safer treatment for serious side effect of bone marrow transplant

  John Levine & Aaron Etra

  14/12/22

  2 items of Media coverage

  Press/Media

• Mount Sinai Hospital: Experimental Cancer Therapy Shows Success In More Than 70 Percent Of Patients In Global Clinical Trials

  Ajai Chari

  14/12/22

  1 item of Media coverage

  Press/Media

• Oncotarget | Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

  Samir Parekh & Violetta V. Leshchenko

  13/12/22

  2 items of Media coverage

  Press/Media

• ‘Exciting’ responsiveness to talquetamab for r/r MM

  Ajai Chari

  13/12/22

  2 items of Media coverage

  Press/Media

• Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

  Ajai Chari

  10/12/22 → 13/12/22

  11 items of Media coverage

  Press/Media

• SABCS: Updated Analysis Confirms Endocrine Therapy Effective With/Without Chemo

  Joseph Sparano

  12/12/22 → 13/12/22

  83 items of Media coverage

  Press/Media

• Experimental cancer immunotherapy has over 70% response rate

  Ajai Chari

  13/12/22

  2 items of Media coverage

  Press/Media

• Antibody Treatment Makes Inroads Against Multiple Myeloma

  Ajai Chari

  12/12/22 → 13/12/22

  104 items of Media coverage

  Press/Media

• Antibody Treatment Makes Inroads Against Multiple Myeloma.(talquetamab)

  Ajai Chari

  12/12/22

  1 item of Media coverage

  Press/Media

• SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

  Joseph Sparano

  12/12/22

  1 item of Media coverage

  Press/Media

• Experimental cancer therapy shows 73 pc success rate in trials: Study

  Ajai Chari

  10/12/22 → 12/12/22

  5 items of Media coverage

  Press/Media

• Mount Sinai: Experimental Cancer Therapy Shows Success in More Than 70 Percent of Patients in Global Clinical Trials

  Ajai Chari

  12/12/22

  1 item of Media coverage

  Press/Media

• Medical Bulletin 12/December/2022

  Ajai Chari

  12/12/22

  1 item of Media coverage

  Press/Media

• SABCS: Updated Analysis Confirms Endocrine Therapy Effective With/Without Chemo; Findings seen among HR-positive, HER2-negative, node-negative early breast cancer patients with recurrence score of 11 to 25.

  Joseph Sparano

  12/12/22

  1 item of Media coverage

  Press/Media

• Experimental Cancer Therapy Shows Success in More Than 70 Percent of Patients in Global Clinical Trials

  Ajai Chari

  12/12/22

  1 item of Media coverage

  Press/Media

• Off-the-shelf immunotherapy could offer new hope for patients with hard-to-treat multiple myeloma

  Ajai Chari

  12/12/22

  1 item of Media coverage

  Press/Media

• Experimental cancer therapy shows success in

  Ajai Chari

  11/12/22

  1 item of Media coverage

  Press/Media

• ‘New lease on life’: Bone marrow cancer therapy successful in 73% of patients

  Ajai Chari

  10/12/22

  1 item of Media coverage

  Press/Media

• New Findings from Icahn School of Medicine at Mount Sinai Describe Advances in Multiple Myeloma (Trial Designs and Endpoints for Immune Therapies In Multiple Myeloma)

  Joshua Richter, Samir Parekh, Sundar Jagannath & Ajai Chari

  8/12/22

  1 item of Media coverage

  Press/Media

• TAILORx Update Confirms Intermediate-Risk Breast Cancer Patients Can Forgo Chemotherapy

  Joseph Sparano

  8/12/22

  1 item of Media coverage

  Press/Media

• Exact Sciences Highlights The Impact Of Precision Oncology Portfolio On Breast Cancer Treatment With 10 New Data Presentations At SABCS® 2022'

  Joseph Sparano

  6/12/22 → 7/12/22

  2 items of Media coverage

  Press/Media